Wynnewood, PA (PRWEB) May 12, 2011
Olfactory Biosciences Corp. (OTC Markets: OLFC) announced today that it has formed a new subsidiary with Incredible Scents, Inc. ( ISI ), called BEHAVIORAL SCIENCE, INC., to manufacture and distribute a new advanced line of NOXO Wellness products in combination with ISI’s popular enhanced nasal delivery system. The new company has the only product line of its type and will be the leading producer of non-invasive behavioral modification and wellness products that provide relief to common health problems such as smoking cessation or weight control, memory enhancement, as examples. http://www.noxowellness.com
Behavioral Science, Inc. uses NOBEL Prize science related to discoveries of odorant receptors in the nose and the organization of the olfactory system, and has developed unique NOXO Health and Wellness Products in combination with ISI’s efficient nasal delivery system device, that are affordable and made from all natural ingredients.
NOXO ingredients are proprietary formulation of Phytonutrients and Phytochemicals and combined with ISI’s new and advanced nasal delivery system includes the following first 7 products.
The new Behavioral Science Brand product line is well proven and will be successfully marketed to distributors starting July 2011 and presently consists of the following that are all enhanced with ISI’s unique, patented and FDA listed Nasal Delivery System Device.
Behavioral Science Brand Product Line (initial 7 products)
1. NOXO Sleep Easy™ with SILENT SNOOZ ®
2. ISI Advanced Delivery NOXO Memory Enhancer™
3. ISI’s Easy Use NOXO Appetite Control™
4. ISI’s Quick Delivery NOXO Sweets Control™
5. NOXO QuitSmoking™with ISI’s Nasal Delivery Device
6. ISI’s Controlled Release NOXO Anxiety Relief™
7. NOXO Stress Relief™ ISI's 24 Hour Nasal Delivery Device
ABOUT INCREDIBLE SCENTS, INC.
The co-founders of Incredible Scents, Inc. have 11 years of experience in marketing the existing product line and will continue with the new unique product line through Behavioral Science. With positive feedback already received from retail buyers as well as several hundred thousand customers. The new product line launch is directed through U.S. retail chain stores. Wholesale Representatives and soon will implement an aggressive direct marketing program to Internet and Retail consumers.
Incredible Scents product line is presently available in 40,000 stores nation wide including all CVS, Rite Aid, Duane Reade, Wakefern (Shoprite supermarkets), Cardinal Health, The Vitamin Shoppe, McKesson, Shoppers Drug Mart (largest drug chain in Canada) and many smaller nationwide drug chains.
ABOUT OLFACTORY BIOSCIENCES CORP
Olfactory Biosciences Corp.’s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common health problems such as smoking cessation or weight control, as examples. The company has taken NOBEL Prize science related to discoveries of odorant receptors in the nose and the organization of the olfactory system, and has developed unique wellness products that are affordable and made from natural ingredients.
Olfactory Biosciences Corp. offers the most advanced and innovative wellness products with the potential to change the way we approach wellness issues today. Olfactory Biosciences Corp’s unique advantages will make the new Behavioral Science products the most sought-after wellness products in the alternative medicine market, creating a growth rate ten times higher than most in the this growing category.
Consumers concerned about their health are looking for alternatives to replace conventional, over-the-counter consumer medical products. Behavioral Science will provide natural wellness products that are both effective and affordable. http://www.noxoinfo.com
Investor & Media Relations:
Safe Harbor for Public Companies
Statements contained in this release that are not strictly historical are "forward-looking statements." Such forward-looking statements are sometimes identified by words such as "intends," "anticipates," "believes," "expects," and "hopes." The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include, but are not limited to, demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders. Olfactory Biosciences Corp., "The Company" currently does not file periodic filings with the Securities and Exchange Commission but will publish financials on the Olfactory Biosciences Corp. website as they become available.
Olfactory Biosciences Corp., Inc.
333 E. Lancaster Ave.
Wynnewood, PA 19096
# # #